🎃The Funding Letter #1279: October 31

MapLight, Seurat, SkyCell, and more…

October 31, 2023


Happy Halloween! This spooky edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from Abridge below!

Hit the Gong 🧟‍♂️⚰️

Source: @crushing_quota

Daily Deals 👻☠️

🌎 Americas

MapLight operates a biopharmaceutical company that uses proprietary optogenetics and a 3D spatial transcriptomics platform to identify a pipeline of targeted therapies for a spectrum of serious CNS disorders, enabling healthcare professionals to improve the lives of patients with CNS disorders. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $225M, Series C

Round Investors: Novo Holdings (lead), 5AM Ventures, Cowen Healthcare Investments

🚀Growth Focus: Develop multiple clinical candidates to treat neurological and psychiatric disorders, including Phase 2 studies for ML-007C-MA in 2024 in schizophrenia and Alzheimer's disease.

HQ: Palo Alto, CA

Industry: Biotechnology Research

Employee Count: 55 (⚡15% increase in last 6 months)

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!